Cwm, LLC Heron Therapeutics, Inc. Transaction History

Cwm, LLC

$24.1 Billion
Q4 2024

A detailed history of Cwm, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 1,429 shares of HRTX stock, worth $2,929. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,429

Previous 10,992 87.0%

Holding current value

$2,929

Previous $22,000 90.91%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$1.06 - $2.12 $10,136 - $20,273	-9,563 Reduced 87.0%	1,429 $2,000
Q3 2024 Oct 08, 2024	BUY	$1.73 - $3.67 $11,981 - $25,418	6,926 Added 170.34%	10,992 $22,000
Q2 2024 Jul 09, 2024	BUY	$2.32 - $3.86 $9,412 - $15,660	4,057 Added 45077.78%	4,066 $14,000
Q1 2024 Apr 05, 2024	BUY	$1.71 - $3.06 $15 - $27	9 New	9 $0
Q2 2023 Aug 03, 2023	SELL	$1.11 - $2.88 $74 - $192	-67 Reduced 12.96%	450 $1,000
Q1 2023 Apr 28, 2023	SELL	$1.51 - $3.25 $1,355 - $2,918	-898 Reduced 63.46%	517 $1,000
Q4 2022 Feb 01, 2023	SELL	$2.25 - $4.67 $978 - $2,031	-435 Reduced 23.51%	1,415 $4,000
Q2 2022 Jul 28, 2022	SELL	$2.3 - $6.29 $299 - $817	-130 Reduced 6.57%	1,850 $5,000
Q1 2022 Apr 21, 2022	BUY	$4.63 - $9.94 $7,083 - $15,208	1,530 Added 340.0%	1,980 $11,000
Q4 2020 Sep 15, 2021	BUY	$14.61 - $22.14 $6,574 - $9,963	450 New	450 $7,000
Q4 2020 Jan 27, 2021	SELL	$14.61 - $22.14 $6,574 - $9,963	-450 Closed	0 $0
Q3 2020 Sep 15, 2021	BUY	$13.67 - $17.77 $6,151 - $7,996	450 New	450 $7,000
Q3 2020 Oct 19, 2020	SELL	$13.67 - $17.77 $6,151 - $7,996	-450 Closed	0 $0
Q2 2020 Sep 15, 2021	SELL	$10.89 - $21.47 $7,623 - $15,029	-700 Reduced 60.87%	450 $7,000
Q2 2020 Jul 22, 2020	BUY	$10.89 - $21.47 $7,623 - $15,029	700 Added 155.56%	1,150 $17,000
Q1 2020 Sep 15, 2021	SELL	$10.23 - $24.56 $7,161 - $17,192	-700 Reduced 60.87%	450 $7,000
Q1 2020 Apr 28, 2020	BUY	$10.23 - $24.56 $7,161 - $17,192	700 Added 155.56%	1,150 $14,000
Q4 2019 Sep 14, 2021	SELL	$17.42 - $26.61 $13,692 - $20,915	-786 Reduced 63.59%	450 $7,000
Q4 2019 Jan 27, 2020	BUY	$17.42 - $26.61 $13,692 - $20,915	786 Added 174.67%	1,236 $29,000
Q3 2019 Sep 14, 2021	SELL	$16.36 - $21.39 $11,452 - $14,973	-700 Reduced 60.87%	450 $7,000
Q3 2019 Oct 22, 2019	BUY	$16.36 - $21.39 $11,452 - $14,973	700 Added 155.56%	1,150 $21,000
Q2 2019 Sep 14, 2021	SELL	$16.93 - $26.22 $3,386 - $5,244	-200 Reduced 30.77%	450 $7,000
Q2 2019 Jul 31, 2019	BUY	$16.93 - $26.22 $3,386 - $5,244	200 Added 44.44%	650 $12,000
Q1 2019 Sep 02, 2021	SELL	$23.15 - $28.34 $4,630 - $5,668	-200 Reduced 30.77%	450 $0
Q1 2019 Apr 22, 2019	BUY	$23.15 - $28.34 $15,047 - $18,421	650 New	650 $16,000

Others Institutions Holding HRTX

# of Institutions

173

Shares Held

114M

Call Options Held

Put Options Held

32.4K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $243M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account